Bayer Overview

  • Year Founded
  • 1863

Year Founded

  • Status
  • Public

  • Employees
  • 87,775

Employees

  • Stock Symbol
  • BAYN

Stock Symbol

  • Investments
  • 109

  • Share Price
  • $59.99
  • (As of Thursday Closing)

Bayer General Information

Description

Bayer is a German healthcare and agriculture conglomerate. Healthcare accounts for close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total sales). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, a segment that was expanded through its 2018 acquisition of Monsanto.

Contact Information

Website
www.bayer.com
Formerly Known As
Farbenfabriken Bayer, Friedr. Bayer et comp.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Kaiser-Wilhelm-Allee 1
  • 51373 Leverkusen
  • Germany
+49 0214
Primary Industry
Conglomerates
Other Industries
Pharmaceuticals
Agricultural Chemicals
Stock Exchange
ETR
Corporate Office
  • Kaiser-Wilhelm-Allee 1
  • 51373 Leverkusen
  • Germany
+49 0214

Bayer Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer Stock Performance

As of 19-Nov-2026, Bayer’s stock price is $59.99. Its current market cap is $58.9B with 982M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$59.99 $61.49 $30.73 - $64.84 $58.9B 982M 2.33M -$1.71

Bayer Financials Summary

As of 30-Sep-2026, Bayer has a trailing 12-month revenue of $53.2B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 91,379,459 81,083,151 56,244,174 78,926,956
Revenue 53,175,940 51,408,880 50,432,298 51,546,827
EBITDA 6,269,389 3,442,675 4,232,089 4,600,985
Net Income (1,681,209) (4,083,382) (2,761,516) (3,182,384)
Total Assets 128,675,920 122,795,828 115,347,395 128,512,684
Total Debt 49,244,744 42,818,380 42,348,155 47,392,914
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bayer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bayer is a German healthcare and agriculture conglomerate. Healthcare accounts for close to half of the company's sales
Conglomerates
Leverkusen, Germany
87,775 As of 2026

London, United Kingdom
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bayer Competitors (3)

One of Bayer’s 3 competitors is GSK, a Corporation company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GSK Corporation London, United Kingdom
UPL Corporation Mumbai, India
Merck Corporation Darmstadt, Germany
You’re viewing 3 of 3 competitors. Get the full list »

Bayer Patents

Bayer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4837922-A1 Antibodies and radiopharmaceutical complexes targeting ceacam5 Pending 10-May-2025
WO-2026233830-A1 Device for the targeted application of a liquid to an agricultural field Pending 09-May-2025
WO-2026234145-A1 Lactam-derivatives as sos1 inhibitors Pending 09-May-2025
WO-2026236473-A1 Magnetic resonance contrast media injector system Pending 08-May-2025
WO-2026236478-A1 Magnetic resonance contrast media injector system Pending 08-May-2025
To view Bayer’s complete patent history, request access »

Bayer Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bayer Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Investments & Acquisitions (109)

Bayer’s most recent deal was a Merger/Acquisition with Perfuse Therapeutics for . The deal was made on 17-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Perfuse Therapeutics 17-Jun-2026 Merger/Acquisition Drug Discovery
Attralus (Portfolio of 2 Investigational Imaging Agents for Diagnosis of Cardiac Amyloidosis) 12-Jan-2026 Corporate Asset Purchase Buildings and Property
Ukko 25-Jun-2025 Later Stage VC Drug Discovery
Aferna 04-Jun-2025 Early Stage VC Other Commercial Products
Cara Care 18-Mar-2025 Merger/Acquisition Application Software
You’re viewing 5 of 109 investments and acquisitions. Get the full list »

Bayer ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

20.24 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Bayer’s complete esg history, request access »

Bayer Exits (34)

Bayer’s most recent exit was on 02-Oct-2024 from Guardian Agriculture. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Guardian Agriculture 02-Oct-2024 Completed
Mothus 04-Dec-2023 Completed
Blackford Analysis 18-Jan-2023 Completed
Projini 01-Jun-2021 Completed
  • 2 buyers
Senti Biosciences Holdings 06-Jan-2021 Later Stage VC Completed
  • 21 buyers
You’re viewing 5 of 34 exits. Get the full list »

Bayer Affiliates

Subsidiaries (50)

Name Industry Location Year Founded
Bayer World Investments Hoofddorp, Netherlands 2022
Bayer Global Investments Hoofddorp, Netherlands 2022
Natsana Dusseldorf, Germany 2019
Perfuse Therapeutics South San Francisco, CA 2018
KaNDy Therapeutics Stevenage, United Kingdom 2017
You’re viewing 5 of 50 affiliates. Get the full list.  »

Bayer FAQs

  • When was Bayer founded?

    Bayer was founded in 1863.

  • Where is Bayer headquartered?

    Bayer is headquartered in Leverkusen, Germany.

  • What is the size of Bayer?

    Bayer has 87,775 total employees.

  • What industry is Bayer in?

    Bayer’s primary industry is Conglomerates.

  • Is Bayer a private or public company?

    Bayer is a Public company.

  • What is Bayer’s stock symbol?

    The ticker symbol for Bayer is BAYN.

  • What is the current stock price of Bayer?

    As of 19-Nov-2026 the stock price of Bayer is $59.99.

  • What is the current market cap of Bayer?

    The current market capitalization of Bayer is $58.9B.

  • What is Bayer’s current revenue?

    The trailing twelve month revenue for Bayer is $53.2B.

  • Who are Bayer’s competitors?

    GSK, UPL, and Merck are competitors of Bayer.

  • What is Bayer’s annual earnings per share (EPS)?

    Bayer’s EPS for 12 months was -$1.71.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process